Lindsey K. Galbo-Thomma, Ph.D.

Research

My overarching goal as a researcher is to contribute important findings that will improve the health and well-being of people who use drugs. To do so, I investigate the interactions between drugs and behavior using methods and concepts in behavioral and receptor pharmacology. Experiments are then designed utilizing highly translational preclinical models and assays measuring a variety of biobehavioral endpoints. This research is also critical for characterizing the potential efficacy of novel pharmacotherapies for substance use disorders.

As a NIDA T32 Appointed Post-Doctoral Research Fellow in the laboratory of Dr. Charles P. France, I will extend my knowledge of methods and concepts in behavioral pharmacology by exploring various operant procedures for characterizing the effects of drugs on behavior. I will also develop expertise in physiological techniques, such as telemetry and head plethysmography, and broaden my knowledge in assessing drug effects on cognitive behavior. My studies will primarily focus on opioid and cannabinoid pharmacology.

In addition to my research endeavors, I am passionate about science and drug policy advocacy and outreach. I was a 2020 ASPET Washington Fellow, held various roles with the non-profit organization Students for Sensible Drug Policy and have been involved in many harm reduction-oriented direct service and outreach opportunities. Lastly, I was selected as the 2023-2024 ACNP/AMP BRAD Fellow and am deeply committed to animal research advocacy.

Awards & Accomplishments

NIDA T32 Post-Doctoral Fellowship (2023 – Present), Training in Drug Abuse Research: Behavior and Neurobiology, University of Texas Health Science Center San Antonio

2023-2024 American College of Neuropsychopharmacology/Americans for Medical Progress Biomedical Research Awareness Day 2023-2024 Fellow

NIAAA F31 Individual Pre-Doctoral Fellowship (2022 – 2023), Cognitive Consequences of EtOH Consumption in Group-Housed Nonhuman Primates, Wake Forest University School of Medicine

NIAAA T32 Pre-Doctoral Fellowship (2019 – 2022), Training in the Neurobiology of Alcohol Abuse, Wake Forest University School of Medicine

2020 American Society for Pharmacology and Experimental Therapeutics Washington Fellow

Publications

LK Galbo-Thomma and PW Czoty (2023) The use of touchscreen-based methods to characterize the effects of psychoactive drugs on executive function in nonhuman primates. Current Pharmacology Reports, in press.

Galbo-Thomma LK, Davenport AT, Epperly PM, Czoty PW (2023) Influence of social rank on the development of long-term ethanol drinking trajectories in cynomolgus monkeys. ACER. PMID: 37553910

Stinson BT, Galbo LK, Flynn SM, Gouin A, Epperly PM, Davenport AT, Czoty PW (2022). Punishment of ethanol choice in rhesus monkeys. Behav Pharmacol, 33(6), 395-401. PMID: 35942846

Hanlon CA, Smith HR, Epperly PM, Collier M, Galbo LK, Czoty PW (2022) Priming the pump? Evaluating the effect of multiple intermittent theta burst sessions on cortical excitability in a nonhuman primate model. Brain Stimulation, 15 (3), 676-677. PMID: 35398479

Galbo LK, Davenport AT, Daunais JB, Epperly PM, Stinson BT, Czoty PW (2022) Social dominance in monkeys: lack of effect on ethanol self-administration during schedule induction. Alcohol, 98, 1-7. PMID: 34728320

Tryhus AM, Epperly PM, Davenport AT, Galbo LK, Czoty PW (2021) Effect of chronic binge-like alcohol drinking on initial cocaine reinforcement in rhesus monkeys. Drug and Alcohol Dependence, 223, 108707. PMID: 33865211